cabergoline has been researched along with Hypopituitarism in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Akirov, A; Duskin-Bitan, H; Masri-Iraqi, H; Rudman, Y; Shimon, I | 1 |
| Akirov, A; Ayalon-Dangur, I; Duskin-Bitan, H; Gorshtein, A; Robenshtok, E; Shimon, I; Tsvetov, G | 1 |
| Miller, KK; Tritos, NA | 1 |
| Bakoto, N; Baleriaux, D; Boscolo, M; Corvilain, B; Devuyst, F | 1 |
| Benbassat, C; Lifshitz, A; Shimon, I; Tirosh, A | 1 |
| Brue, T; Castinetti, F; Cebula, H; Goichot, B; Graillon, T; Képénékian, L | 1 |
| Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S | 1 |
| Díez, JJ; Iglesias, P | 1 |
| Byrne, JV; Dobrescu, R; Grossman, AB; Karavitaki, N; Wass, JA | 1 |
| Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P | 1 |
| Gomes, MC; Knoepfelmacher, M; Melo, ME; Mendonca, BB | 1 |
| Ball, SG; Connolly, V; James, RA; Kane, P; Kelly, WF; Kendall-Taylor, P; Mathias, D; Perros, P; Quinton, R; Sibal, L; Vaidya, B | 1 |
| Davies, JS; George, LD; Nicolau, N; Scanlon, MF | 1 |
| Cappabianca, P; Colao, A; Di Salle, F; Di Sarno, A; Di Somma, C; Faggiano, A; Landi, ML; Lombardi, G; Pivonello, R; Rossi, FW | 1 |
2 review(s) available for cabergoline and Hypopituitarism
| Article | Year |
|---|---|
Diagnosis and Management of Pituitary Adenomas: A Review.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Child; Female; Human Growth Hormone; Humans; Hypopituitarism; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2023 |
Acute aseptic meningitis as the initial presentation of a macroprolactinoma.
Topics: Adult; Anti-Bacterial Agents; Blindness; Cabergoline; Combined Modality Therapy; Ergolines; Fever; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Hypopituitarism; Male; Meningitis, Aseptic; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma; Sella Turcica; Third Ventricle; Thyroxine | 2014 |
3 trial(s) available for cabergoline and Hypopituitarism
| Article | Year |
|---|---|
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hypopituitarism; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies | 2013 |
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin | 2002 |
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Retrospective Studies | 2001 |
9 other study(ies) available for cabergoline and Hypopituitarism
| Article | Year |
|---|---|
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma.
Topics: Adult; Cabergoline; Humans; Hypogonadism; Hypopituitarism; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Testosterone | 2022 |
Natural history of nonfunctioning pituitary macroadenomas followed without intervention: A retrospective cohort study.
Topics: Adenoma; Aged; Aged, 80 and over; Cabergoline; Humans; Hypopituitarism; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Treatment Outcome | 2023 |
Hypopituitarism patterns and prevalence among men with macroprolactinomas.
Topics: Adult; Aged; Aged, 80 and over; Cabergoline; Ergolines; Humans; Hypopituitarism; Male; Middle Aged; Prevalence; Prolactinoma; Retrospective Studies; Testosterone; Young Adult | 2015 |
Long-term outcome of macroprolactinomas.
Topics: Adolescent; Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; France; Humans; Hyperprolactinemia; Hypopituitarism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Misdiagnosis due to the hook effect in prolactin assay.
Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Female; Glucocorticoids; Humans; Hypopituitarism; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prednisolone; Prolactin; Prolactinoma; Thyroxine | 2008 |
Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
Topics: Anemia; Antineoplastic Agents; Biomarkers, Tumor; Cabergoline; Chronic Disease; Dopamine Agonists; Drug Therapy, Combination; Early Detection of Cancer; Ergolines; Hematocrit; Hemoglobins; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypogonadism; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyroxine; Treatment Outcome | 2011 |
Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma.
Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Ergolines; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Prolactin; Prolactinoma; Stroke | 2004 |
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cabergoline; Combined Modality Therapy; Decompression, Surgical; Ergolines; Female; Humans; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Gland; Pituitary Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vision Disorders | 2004 |
Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas.
Topics: Adolescent; Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Insulin-Like Growth Factor I; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Recovery of Function; Treatment Outcome | 2000 |